COVID-19, also known as Covid or corona, is the disease caused by the coronavirus SARS-CoV-2. It is still present in the Netherlands. Information about the virus, the COVID-19 vaccinations and the latest figures is available on these pages.
News about COVID-19 and vaccination
New COVID-19 vaccination round for risk groups this autumn
The new COVID-19 vaccination round will start on 16 September 2024. For people who are at higher risk, the COVID-19 vaccination offers more effective protection against hospital admission or death due to COVID-19.
New research portal for people with post-COVID
Starting today, people with post-COVID can sign up to take part in scientific research. They can register through the national portal at postcovidonderzoek.nl, which is part of the Post-COVID Network Netherlands.
Well-being should be considered from the start when formulating policy during pandemic, health emergency or other crisis
Monitoring well-being from the outset and throughout the duration of a pandemic, health emergency or other crisis provides helpful input in making policy choices.
Study on the effectiveness of COVID-19 measures in the Netherlands
The measures implemented in the Netherlands during the COVID-19 crisis were effective against the spread of the SARS-CoV-2 virus. This is the outcome of a study conducted by RIVM.
Air pollution increases risk of infection and severity of illness from COVID-19
People who live in areas with poor air quality are more likely to become infected with SARS-CoV-2. Moreover, the symptoms of COVID-19 are more severe, leading to more hospitalisations and deaths. This is the outcome of a study conducted by RIVM, Utrecht University, Wageningen University & Research and the Netherlands Municipal Public Health Services and Medical Assistance in Accidents and Disasters.
More than 2.7 million COVID-19 vaccinations administered in the 2023 autumn round
In the 2023 autumn round, more than 2,731,000 people in the Netherlands received a COVID-19 vaccination. Vaccination coverage for people over 60 is currently 50.5%. Vaccination coverage varies by age group and region. COVID-19 vaccination was available until 22 December 2023.
FAQ about COVID-19 and the coronavirus SARS-CoV-2
Other coronaviruses
Coronaviruses mostly affect the respiratory system (nose, mouth and airways).
Besides SARS-CoV-2, other examples of coronaviruses are Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV1).